HDAC9 and amyotrophic lateral sclerosis: By using a potent HDAC inhibitor, ACY-738, and by combining transcriptomic and lipidomic analysis, our data demonstrated a link between epigenetic modifications and lipid metabolism defects in the spinal cord of a FUS mouse model of ALS.